Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-165514
Filing Date
2025-07-25
Accepted
2025-07-25 16:57:05
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B3 d921992d424b3.htm 424B3 298903
2 GRAPHIC g921992g0723205634571.jpg GRAPHIC 3336
3 GRAPHIC g92305dsp51.jpg GRAPHIC 31124
4 GRAPHIC g92305dsp52a.jpg GRAPHIC 4248
  Complete submission text file 0001193125-25-165514.txt   353847
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-279773 | Film No.: 251152244
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)